← SynDRA
Ginsenoside Rd
SynDRA canonical compound SYN2076229 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Mechanism of action | apoptosis stimulant |
| Indication | immunostimulant |
| Disease area | Immunology |
Mechanisms of action (all sources)
- apoptosis stimulant
- calcium channel blocker
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Gypenoside VIII
- Chikusetsusaponin fk7
- WB232T95AV
- CHEBI:67988
- RefChem:37442
- UNII-WB232T95AV
- DTXCID701516233
- GS-Rd
- G-Rd
- (20S)-ginsenoside Rd
- Ginsenoside Rd (Standard)
- (GS)-Rd
- Gypenoside VIII (Standard)
- SCHEMBL669260
- HMS3885A14
- HY-N0043
- MSK40199
- EINECS 258-118-5
- BDBM50317539
- s3931
- AKOS037514671
- CCG-270588
- CS-3839
- EBC-618393
- NCGC00522501-01
- G0550
- G3456
- C20725
- (3beta,12beta,20S)-20-[(beta-D-glucopyranosyl)oxy]-3-[(beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl)oxy]dammar-24-en-12-ol
- 2-O-beta-D-glucopyranosyl-(3beta,12beta)-20-(beta-D-glucopyranosyloxy)-12-hydroxydammara-24-en-3-yl-beta-D-glucopyranoside
- 3-O-(beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranosyl)-20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol
- EBC-616763
- orb1304899
- BRD-A84810646-001-01-6
- PD062752
- AKOS037748852
- orb3140526
- WLZ4735
Look up Ginsenoside Rd in the interactive SynDRA portal →